Using primary human and mouse (Eμ-Tcl1 Tg) CLL cells alongside a highly selective PI3Kδi, GS-9820,30 we demonstrate that intrinsic apoptosis driven by Bim is the central in vivo therapeutic mechanism for PI3Kδi. This evidence concerns the gene BCL2L11 and B-cell chronic lymphocytic leukemia.